Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merrimack Pharmaceuticals

15.13
0.0000
Volume:- -
Turnover:- -
Market Cap:223.75M
PE:1.08
High:15.13
Open:15.13
Low:15.13
Close:15.13
Loading ...
May 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Voluntary Delisting

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Mar 27, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 07, 2023

Major Issues Report

Form 8-K - Current report